Shenzhen Kangzhe was awarded the “Top Ten Health Innovative Enterprises” prize by “MD WEEKLY”

Company News

The 10th anniversary of publication of “MD WEEKLY” development symposium was held in January 2016, Beijing. On the meeting, SHENZHEN KANGZHE PHARMACEUTICAL COMPANY LTD. was awarded the “Boost Pharmaceutical Industry Forward? Top Ten Health Innovative Enterprises” prize.

SHENZHEN KANGZHE PHARMACEUTICAL COMPANY LTD is a wholly owned subsidiary company of CMS (stock code: HK867). As a leading supplier of marketing, promotion and sales services for prescription drugs in China, CMS always insists on creating value for physicians, patients and pharmaceutical manufacturers, devotes continusly the innovation of human health, and promote the sustainable development of China pharmaceutical industry as its mission.